Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 489608, 2 pages
http://dx.doi.org/10.1155/2012/489608
Editorial

Atherosclerosis in Rheumatoid Arthritis

1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IFIMAV, 39008 Santander, Spain
2Department of Rheumatology, Institute of Medicine, University of Debrecen Medical and Health Sciences Center, 98 Nagyerdei Street, Debrecen H-4032, Hungary
3Department of Rheumatology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
4Research Unit of Cardiovascular Pathophysiology and Genomics, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg 2193, South Africa

Received 30 September 2012; Accepted 30 September 2012

Copyright © 2012 Miguel A. González-Gay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, and J. Martin, “Rheumatoid arthritis: a disease associated with accelerated atherogenesis,” Seminars in Arthritis and Rheumatism, vol. 35, no. 1, pp. 8–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. H. Dessein, B. I. Joffe, M. G. Veller et al., “Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis,” Journal of Rheumatology, vol. 32, no. 3, pp. 435–442, 2005. View at Google Scholar · View at Scopus
  3. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, M. J. Lopez-Diaz et al., “HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis,” Arthritis Care and Research, vol. 57, no. 1, pp. 125–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Rodríguez-Rodríguez, C. González-Juanatey, R. Palomino-Morales et al., “TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis,” Atherosclerosis, vol. 216, no. 1, pp. 125–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez, J. Martin, and J. Llorca, “Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 38, no. 2, pp. 67–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Kerekes, P. Soltész, M. T. Nurmohamed et al., “Validated methods for assessment of subclinical atherosclerosis in rheumatology,” Nature Reviews Rheumatology, vol. 8, no. 4, pp. 224–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Rodríguez-Rodríguez, C. González-Juanatey, M. García-Bermúdez et al., “CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study,” Arthritis Research and Therapy, vol. 13, no. 4, article R133, 2011. View at Google Scholar · View at Scopus
  8. R. Palomino-Morales, C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez et al., “A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 12, no. 2, article 71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Gómez, J. Conde, M. Scotece, J. J. Gómez-Reino, F. Lago, and O. Gualillo, “What's new in our understanding of the role of adipokines in rheumatic diseases?” Nature Reviews Rheumatology, vol. 7, no. 4, pp. 528–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Gonzalez-Gay, M. T. Garcia-Unzueta, C. Gonzalez-Juanatey et al., “Anti-TNF-α therapy modulates resistin in patients with rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 26, no. 2, pp. 311–316, 2008. View at Google Scholar · View at Scopus
  11. C. Gonzalez-Juanatey, J. Llorca, A. Sanchez Andrade, C. Garcia-Porrua, J. Martin, and M. A. Gonzalez-Gay, “Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab,” Clinical and Experimental Rheumatology, vol. 24, no. 3, pp. 309–312, 2006. View at Google Scholar · View at Scopus
  12. C. Barnabe, B. J. Martin, and W. A. Ghali, “Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis,” Arthritis Care and Research, vol. 63, no. 4, pp. 522–529, 2011. View at Google Scholar · View at Scopus
  13. C. Popa, L. J. H. Van Tits, P. Barrera et al., “Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 868–872, 2009. View at Publisher · View at Google Scholar · View at Scopus